Last Friday, Kraig Biocraft Laboratories Inc (OTC:KBLB) let the fall begin. Suddenly the stock lost 3.31% of its market price, KBLB_chart4.pngwhile its traded volume totaled over 2 million shares.

Apparently, something has made  investors sell their shares and KBLB moved down.

Last Thursday, Kraig announced that the company was featured in a prestigious publication by the Massachusetts Institute of Technology, though the review couldn’t support KBLB stock.

Just about a month ago, Kraig Laboratories were climbing up on reported optimistic news. However, it seemed quite speculative, considering the fact that over the last months some promoters have used the positive announcements to push up the stock and that strategy was successful.[BANNER]

Kraig_Labs_logo.gifDespite the previous impressive gains, Kraig continues to exist on no sufficient cash resources and unclear cooperations.

The most astonishing fact here is that the company has been operating with only one employee, the CEO Kim Thompson, who still manages to sustain KBLB’s existence with no income and liabilities of over $3 million.

Meanwhile, the stock keeps its uncertain position, mostly relying on provocative announcements to pump up its share price.